journal article·2026-11

Dinuclear platinum(II)-anthracene complexes as lysosomal-localized photodynamic anticancer agents

Yi-Fang Zhong, Yuchen Li, Xing-Ke Song, Hong-Ze Zhang, Jincan Chen, Lanmei Chen

Dyes and Pigments· Volume 254
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Metal complexes synthesis and properties · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
2. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
3. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
4. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
5. Activatable photosensitizers: from fundamental principles to advanced designs
6. Subcellular organelle targeted tumor phototherapy10.1016/j.ccr.2025.216635 ↗
7. NIR-II AIEgens for infectious diseases phototheranostics10.1002/anie.202414259 ↗
8. Manipulating the dynamics of dark excited states in organic materials for phototheranostics10.1021/acs.accounts.0c00688 ↗
9. Oxygen self-sufficient photodynamic therapy10.1016/j.ccr.2020.213714 ↗
10. Smart molecular designs and applications of activatable organic photosensitizers10.1038/s41570-024-00662-7 ↗
11. A type I/II photosensitizer with lysosome-targeting capabilities induces immunogenic cell death in cancer cells to enhance tumor immunotherapy10.1021/acsnano.5c14676 ↗
12. PDT and antitumor immunity: the beginnings of the story10.1007/s43630-024-00627-1 ↗
13. Tumor-microenvironment-activated reactive oxygen species amplifier for enzymatic Cascade cancer starvation/chemodynamic/immunotherapy
14. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
15. Recent progresses in phototherapy-synergized cancer immunotherapy
16. Immunogenic cell death inducing metal complexes for cancer therapy
17. Augmenting cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium(II) metallacycle10.1021/jacs.3c13224 ↗
18. Molecular architectures of multi-anthracene assemblies10.1039/C3CS60315F ↗
19. Anthracene-based endoperoxides as self-sensitized singlet oxygen carriers for hypoxic-tumor photodynamic therapy10.1002/adhm.202403009 ↗
20. Dinuclear anthracene-containing alkynylplatinum(II) terpyridine complexes with photo-modulated self-assembly behaviors10.1039/D0QM00972E ↗
21. An anthracene functionalized BODIPY derivative with singlet oxygen storage ability for photothermal and continuous photodynamic synergistic therapy10.1039/C9TB00180H ↗
22. Near-infrared light triggered photothermal and photodynamic therapy with an oxygen-shuttle endoperoxide of anthracene against tumor hypoxia10.1039/C8PY00289D ↗
23. Anthracene-bisphosphonate based novel fluorescent organic nanoparticles explored as apoptosis inducers of cancer cells10.1039/c3cc44989k ↗
24. Fluorescent mixed ligand copper(II) complexes of anthracene-appended schiff bases: studies on DNA binding, nuclease activity and cytotoxicity10.1039/C5DT00899A ↗
25. A discrete organoplatinum(II) metallacage as a multimodality theranostic platform for cancer photochemotherapy10.1038/s41467-018-06574-7 ↗
26. A supramolecular photosensitizer derived from an Arene-Ru(II) complex self-assembly for NIR activated photodynamic and photothermal therapy10.1038/s41467-022-30721-w ↗
27. A Platinum(II)-based photosensitive tripod as an effective photodynamic anticancer agent through DNA damage10.1002/chem.201703598 ↗
28. Nucleus-localized platinum(II)-triphenylamine complexes as potent photodynamic anticancer agents10.1039/C9QI00738E ↗
29. Weber · Eur J Inorg Chem · 2005 · 2005 · 475510.1002/ejic.200500663 ↗
30. Multiple-color platinum complex with super-large stokes shift for super-resolution imaging of autolysosome escape10.1002/anie.202007878 ↗
31. Determination of the lifetime of singlet oxygen in water-d2 using 9,10-anthracenedipropionic acid, a water-soluble probe10.1021/ja00537a030 ↗
32. Photooxidation of tryptophan: O2(1Δg) versus electron-transfer pathway10.1111/j.1751-1097.1997.tb01883.x ↗
33. A NIR-light-activated and lysosomal-targeted Pt(II) metallacycle for highly potent evoking of immunogenic cell death that potentiates cancer immunotherapy of deep-seated tumors10.1002/anie.202483761 ↗
34. A new approach to sensitize antitumor monofunctional platinum(II) complexes via short time photo-irradiation10.1021/acs.inorgchem.6b02148 ↗
35. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
36. CO/light dual-activatable Ru(II)-conjugated oligomer agent for lysosome-targeted multimodal cancer therapeutics10.1039/D1SC01317C ↗
37. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
38. Cyclometalated iridium(III) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents10.1039/C5SC01955A ↗
39. Flow cytometry of apoptotic cell death10.1016/S0022-1759(00)00233-7 ↗
40. Dual-organelle targeted photosensitizer with AIE characteristics for triple-negative breast cancer photodynamic therapy via apoptosis and immunogenic cell death
41. An albumin-photosensitizer supramolecular assembly with Type I ROS-induced multifaceted tumor cell deaths for photodynamic immunotherapy
42. The distinct roles of ROS in tumor immunity: from mechanisms to immunotherapeutic applications10.1186/s13045-026-01780-z ↗
43. Induction of immunogenic cell death by novel platinum-based anticancer agents10.1016/j.phrs.2022.106556 ↗